5-(3-bromophenyl)-3-((diethylamino)methyl)-5-methylimidazolidine-2,4-dioneas
A compound 5-(3-bromophenyl)-3-((diethylamino)methyl)-5-methylimidazolidine-2,4-dione, its synthesis, use as an antibacterial agent and an inhibitor of Chronic Obstructive Pulmonary Disease (COPD).
1 . A method of treating a bacterial infection in a patient comprising administering to a patient in need thereof a therapeutically effective amount of a 5-(3-bromophenyl)-3-((diethylamino)methyl)-5-methylimidazolidine-2,4-dione compound of formula 1 and a pharmaceutically acceptable carrier:
2 . The method of treating the bacterial infection of claim 1 , wherein the bacterial infection is caused by one or more bacteria.
3 . The method of treating the bacterial infection of claim 2 , wherein the bacterial infection is caused by at least one of a gram positive bacteria, a gram negative bacteria, and a combination thereof.
4 . The method of treating the bacterial infection of claim 3 , wherein the gram positive bacteria is selected from the group consisting of Bacillus cereus, Staphylococcus aureus , and a combination thereof.
5 . The method of treating the bacterial infection of claim 3 , wherein the gram negative bacteria is selected from the group consisting of Pseudomonas aeruginosa, Escherichia coli , and a combination thereof.
6 . A method of treating chronic obstructive pulmonary disease (COPD) inhibition in a patient comprising administering to a patient in need thereof a therapeutically effective amount of a 5-(3-bromophenyl)-3-((diethylamino)methyl)-5-methylimidazolidine-2,4-dione compound of formula 1 and a pharmaceutically acceptable carrier: